Fluoride ion F-18

DB09398ApprovedInvestigationalSmall moleculeRadioactive Diagnostic Agent

Fluoride ion F-18 is a diagnostic radiopharmaceutical agent used as a bone imaging agent to delineate areas of altered osteogenesis. Sodium Fluoride F 18 Injection is a positron emitting radiopharmaceutical, no-carrier added.

Chemical structure of Fluoride ion F-18
Mechanism
Curator reviewed
Primary indication
18F is used as a bone imaging agent to define areas of altered osteogenic activity.Curator reviewed · 2 structured indications
Formula / weight
F · 18.0015 g/mol (avg)
First approval
United States, 2009
Also known as
(18F)-Fluoride · 18F-Fluoride · Fluoride-18 anion
Brand names
  • Sodium Fluoride F-18

Resolves to

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
17Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
34Marketed productsAcross 5 countries and 32 labellers
Sign in
1ATC codeIncluding every combination product, plus 4 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Fluoride ion F-18, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account